Reconfigurable microfluidic integration of a dual-beam laser trap with 
biomedical applications

Lincoln, Bryan; Schinkinger, Stefan; Travis, Kort; Wottawah, Falk; Ebert, Susanne; Sauer, Frank; Guck, Jochen

doi:10.1007/s10544-007-9079-x

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Reconfigurable microfluidic integration of a dual-beam laser trap with biomedical applications

MPS-Authors

There are no MPG-Authors in the publication available

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Lincoln, B., Schinkinger, S., Travis, K., Wottawah, F., Ebert, S., Sauer, F., et al. (2007). Reconfigurable microfluidic integration of a dual-beam laser trap with biomedical applications. BIOMEDICAL MICRODEVICES, 9(5), 703-710. doi:10.1007/s10544-007-9079-x.

Cite as: https://hdl.handle.net/21.11116/0000-0004-B435-5

Abstract

A dual-beam fiber laser trap, termed the optical stretcher when used to deform objects, has been combined with a capillary-based microfluidic system in order to serially trap and deform biological cells. The design allows for control over the size and position of the trap relative to the flow channel. Data is recorded using video phase contrast microscopy and is subsequently analyzed using a custom edge fitting routine. This setup has been regularly used with measuring rates of 50-100 cells/h. One such experiment is presented to compare the distribution of deformability found within a normal epithelial cell line to that of a cancerous one. In general, this microfluidic optical stretcher can be used for the characterization of cells by their viscoelastic signature. Possible applications include the cytological diagnosis of cancer and the gentle and marker-free sorting of stem cells from heterogeneous populations for therapeutic cell-based approaches in regenerative medicine.